Terumo Corp
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
171 / 663
Position in country
2831 / 4811
Return on Assets, %
5.9
-11.9
Net income margin, %
12.4
-12.5
EBITDA margin, %
25.1
-2.5
Debt to Equity, %
18.6
15
Intangible assets and goodwill, %
33
3.9
Revenue CAGR 3Y, %
9.2
12.6
Total Equity change 1Y, %
5.2
0
Revenue Y, % chg
4.1
4.6
P/E
39.3
28.3
P/BV
3.1
1.7
P/S
4.4
3.7
EV/S
4.4
3.2
EV/EBITDA
19.2
-0.2
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
16.7
66.5
Forward P/E
30.8
19.2
Dividend Yield, %
0.8
1.8
Forward Dividend Yield, %
0.9
0.2
Expected dividend per share
0.1
0
Payout Ratio, %
32.3
17.3
Competitors
Ranks
-
Fukuda Denshi Co Ltd
00%
-
Nakanishi Inc
00%
-
Terumo Corp
00%
-
JEOL Ltd
00%
-
Paramount Bed Holdings Co Ltd
00%
-
Sysmex Corp
00%
-
Olympus Corp
00%
-
Abbott Laboratories
00%
-
Nihon Kohden Corp
00%
-
PHC Holdings Corp
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Japan
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
25467.4
Ticker
TRUMY.PK
ISIN
US88156J1051
IPO date
1982-06-21
Availability on Russian exchanges
No
Reporting for
2024-02-09
Date fact. publication of reports
2023-12-31
Company Description
TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: